Clinical Research Directory
Browse clinical research sites, groups, and studies.
Breast Cancer Study Tracking Risk Awareness of Alcohol Consumption and Improving Knowledge in Young Adult Women
Sponsor: Ohio State University Comprehensive Cancer Center
Summary
This randomized trial aims to test the effects of co-created breast cancer counter marketing intervention messages for reducing alcohol consumption and impacting awareness and beliefs about the breast cancer risks from alcohol consumption in young adult women.
Official title: Alcohol Counter Marketing as a Breast Cancer Prevention Strategy in Young Women
Key Details
Gender
FEMALE
Age Range
18 Years - 25 Years
Study Type
INTERVENTIONAL
Enrollment
500
Start Date
2026-03-19
Completion Date
2027-07-01
Last Updated
2026-03-25
Healthy Volunteers
Yes
Conditions
Interventions
Alcohol and Breast Cancer Risk Messages
Participants will be randomized in a 1:1 ratio to the intervention or control arm. In the intervention arm, participants will receive the co-created intervention content. The investigators co-created the intervention content, including visuals and text, through focus groups with young adult women and refined the draft content based on additional feedback from focus groups, thereby ascertaining the views of young adult women. The intervention content aligns with a conceptual framework and includes messaging with the following themes: 1) Risks of breast cancer from alcohol consumption; 2) Efficacy content promoting behavior change; 3) Relevance to young adult women; 4) Mechanisms through which alcohol consumption increases breast cancer risk; 5) Exposing the alcohol industry's deceptive marketing practices; 6) Comparisons to other behavioral risk factors for cancer.
Skin Cancer Risk Messages
Participants in the control arm will receive text only content about skin cancer risk and prevention. This is based on intervention trials in other cancer prevention areas (e.g., tobacco) where the investigators used this type of control, provides a contact-matched comparison relative to the intervention arm, and ensures consistency of the protocol (e.g., timing of completion and content of measures to be completed) across the trial arms.
Locations (1)
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States